Department of Periodontology, School of Dental Medicine, University of Bern, Freiburgstrasse 7, CH-3010, Bern, Switzerland.
Research Section, School of Dental Medicine, University of Bern, Bern, Switzerland.
Clin Oral Investig. 2018 Dec;22(9):3031-3041. doi: 10.1007/s00784-018-2392-3. Epub 2018 Feb 21.
The purpose of this retrospective study was to assess the impact of microbiological diagnostics on the outcomes of periodontal treatment with or without adjunctive use of systemic antibiotics.
Patient files were screened for microbiological analysis before (T1) and after non-surgical periodontal therapy (T2). Medical history, diagnosis, clinical data, and results of the microbiological analysis were extracted from the patient's file. After descriptive statistics, logistic regression analysis was performed to model the presence of 90 and 50% reductions of numbers of sites with probing depths (PD) of ≥ 5 mm at T2 (90%-PD5 and 50%-PD5), respectively, against the presence of bacterial species, clinical diagnosis, and adjunctive use of systemic antibiotics.
Eighteen patients diagnosed with aggressive periodontitis (AP, 17 with adjunctive antibiotics) and 84 with chronic periodontitis (CP, 31 with adjunctive antibiotics) were included in the analysis. Logistic modeling of bacteria at T1 to 90%-PD5 failed to show any statistical significance. Using 50%-PD5, presence of all Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola and in particular of T. denticola at T1 was associated with good response to therapy. Modeling of bacterial presence to 90-%PD5 and to 50-%PD5 at T2 found an association with absence of T. forsythia (90-%PD5 and 50-%PD5) and of T. denticola and Campylobacter rectus (50%-PD5). Modeling bacteria at T1, antibiotic group and oral hygiene at T2 on 50%-PD5 revealed odds ratio (OR) of the adjunctive antibiotic group between 2.70 and 52.4, of the oral hygiene between 3.27 and 4.11, and of the bacteria at T1 up to 28.6 (Porphyromonas gingivalis, T. forsythia, or T. denticola).
Microbiological analysis of the most important species associated with periodontal diseases appears to support a clinically based decision for the adjunctive use of systemic antibiotics.
The present findings appear to support the use microbiological testing to strengthen the clinical decision making process for either using or not using systemic antibiotics in conjunction with non-surgical periodontal therapy.
本回顾性研究旨在评估微生物诊断对牙周治疗结果的影响,包括是否辅助使用全身抗生素。
在非手术牙周治疗前(T1)和后(T2)筛选患者的病历进行微生物分析。从患者病历中提取病史、诊断、临床数据和微生物分析结果。在进行描述性统计后,采用逻辑回归分析模型,分别针对 T2 时探诊深度(PD)≥5mm 的位点数量减少 90%(90%-PD5)和 50%(50%-PD5)的情况,分析细菌、临床诊断和辅助使用全身抗生素的存在情况。
本研究共纳入 18 例侵袭性牙周炎(AP,17 例辅助使用抗生素)和 84 例慢性牙周炎(CP,31 例辅助使用抗生素)患者。T1 时细菌的逻辑模型分析未能显示出任何统计学意义。使用 50%-PD5 时,T1 时所有牙龈卟啉单胞菌、福赛斯坦纳菌和牙髓卟啉单胞菌的存在,特别是牙髓卟啉单胞菌的存在,与治疗反应良好相关。T2 时细菌存在情况对 90%-PD5 和 50%-PD5 的建模发现,T2 时无福赛斯坦纳菌(90%-PD5 和 50%-PD5)和牙髓卟啉单胞菌和直肠弯曲杆菌(50%-PD5)与无应答相关。在 T1 时对细菌、T2 时的抗生素组和口腔卫生情况进行建模,发现辅助抗生素组的优势比(OR)在 2.70 至 52.4 之间,口腔卫生组在 3.27 至 4.11 之间,而 T1 时的细菌组高达 28.6(牙龈卟啉单胞菌、福赛斯坦纳菌或牙髓卟啉单胞菌)。
与牙周病相关的最重要细菌的微生物分析似乎支持基于临床的决策,即辅助使用全身抗生素。
本研究结果似乎支持使用微生物检测来加强临床决策过程,以决定是否在非手术牙周治疗中联合使用或不使用全身抗生素。